|
2025
|
Invention
|
Protocol for treatment of lupus nephritis.
By employing a pharmacodynamic dosing regimen, the ef... |
|
2024
|
Invention
|
Methods for treating lupus nephritis with voclosporin. Provided herein are methods of treatment o... |
|
|
Invention
|
B cell activating factor (baff)-a proliferation inducing ligand (april) dual inhibitors.
Provide... |
|
|
Invention
|
Methods and uses related to administration of voclosporin. Provided herein are methods of treatme... |
|
2022
|
Invention
|
B cell activating factor (baff)-a proliferation inducing ligand (april) dual inhibitors. Provided... |
|
|
G/S
|
Providing educational mentoring services and programs in the field of auto-immune diseases; Provi... |
|
|
Invention
|
Protocol for treatment of lupus nephritis. By employing a pharmacodynamic dosing regimen, the eff... |
|
|
G/S
|
Promoting public awareness of lupus nephritis Medical research services; medical research and dev... |
|
|
G/S
|
Medical research services; medical research and development in the field of lupus nephritis; prov... |
|
|
G/S
|
Advertising services to promote public awareness of lupus
nephritis. Educational services, namel... |
|
|
Invention
|
Protocol to minimize calcineurin inhibitor nephrotoxicity.
Provided herein are methods of employ... |
|
|
Invention
|
Protocol to minimize calcineurin inhibitor nephrotoxicity. Provided herein are methods of employi... |
|
2021
|
G/S
|
Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segm... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of kidney
disorders, lupus nephritis and focal seg... |
|
|
Invention
|
Methods of treating or preventing coronavirus infection.
Provided herein are methods of using vo... |
|
|
Invention
|
Methods of treating or preventing coronavirus infection. Provided herein are methods of using voc... |
|
|
Invention
|
Ophthalmic compositions.
The embodiments disclosed herein relate to ophthalmic compositions comp... |
|
2020
|
G/S
|
Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal seg... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of kidney
disorders, lupus nephritis, and focal se... |
|
|
G/S
|
Promoting public awareness of lupus nephritis Promoting and raising the awareness of lupus nephri... |
|
|
G/S
|
Healthcare services, namely, integrated healthcare services with a network of healthcare provider... |
|
|
G/S
|
Promoting and raising the awareness of lupus nephritis; providing information to patients on lupu... |
|
|
G/S
|
Promoting public awareness of lupus nephritis Educational services, namely, organizing, conductin... |
|
|
G/S
|
Promoting public awareness of lupus nephritis
Educational services, namely, organizing, conductin... |
|
|
G/S
|
Promoting and raising the awareness of lupus nephritis.
Organization and presentation of seminars... |
|
|
G/S
|
Research and development of medicinals and pharmaceuticals Medical information services, namely, ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of kidney diseases and disorders, autoimmune diseas... |
|
|
G/S
|
Research and development of medicinals and pharmaceuticals; conducting clinical trials and patien... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamal... |
|
2019
|
Invention
|
Ophthalmic compositions. The embodiments disclosed herein relate to ophthalmic compositions compr... |
|
2018
|
Invention
|
Improved protocol for treatment of lupus nephritis. By employing a pharmacodynamic dosing regimen... |
|
|
G/S
|
Conducting medical, clinical and patient studies on focal segmental glomerulosclerosis |
|
|
G/S
|
Promoting and raising public awareness of lupus nephritis Research and development activities in ... |
|
2015
|
Invention
|
Topical drug delivery system for ophthalmic use.
Topical drug delivery systems for ophthalmic us... |
|
2014
|
Invention
|
Cyclosporine analogue mixtures and their use as immunomodulating agents.
The invention is direct... |
|
|
Invention
|
Cyclosporine analogue mixtures and their use as immunomodulating agents. TX247 isomers and alkyla... |
|
|
Invention
|
Synthesis of cyclosporin analogs.
The invention is directed to isomeric mixtures of cyclosporine... |
|
|
Invention
|
Cyclosporin analog formulations.
The present disclosure relates to formulations containing cyclo... |
|
|
Invention
|
Deuterated cyclosporine analogs and methods of making the same.
Cyclosporine derivatives are dis... |
|
2011
|
Invention
|
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors. The embodiments dis... |
|
2010
|
Invention
|
Topical drug delivery systems for ophthalmic use. Topical drug delivery systems for ophthalmic us... |
|
2008
|
Invention
|
Cyclosporin analog formulations. The present invention relates to formulations containing cyclosp... |
|
2005
|
Invention
|
Deuterated cyclosporine analogs and methods of making the same. Cyclosporine derivatives are disc... |
|
|
Invention
|
Methods of making deuterated cyclosporin analogs. Cyclosporine derivatives are disclosed which po... |
|
|
Invention
|
Deuterated cyclosporin analogs and their use as immunomodulating agents. Cyclosporine derivatives... |
|
2002
|
Invention
|
Synthesis of cyclosporin analogs. TX247 isomers and alkylated, arylated, and deuterated derivativ... |
|
2000
|
Invention
|
Deuterated cyclosporine analogs and their use as immunomodulating agents. Cyclosporine derivative... |
